Corporate Social Responsibility | Business Wire | PR NewsWire | Marketwire | Realwire | ACN/JCN newswire | 247pressrelease | PRWeb

Chairman of the Board and President Announced to Lead the North Carolina Advanced Medical Technologies Center of Innovation

RESEARCH TRIANGLE PARK, N.C. - 
      J. Greg Davis has been elected Chairman of the Board and Cindy Clark has 
      been appointed President of the North Carolina Advanced Medical 
      Technologies Center of Innovation (NC AMTC). The NC AMTC is a new 
      non-profit corporation established to promote the growth o
Posted : Wed, 04 Nov 2009 20:12:43 GMT
Author : North Carolina Biosciences Organization
Category : Press Release
News Alerts by Email ( click here )
Press Release News | Home
RESEARCH TRIANGLE PARK, N.C. - (Business Wire) J. Greg Davis has been elected Chairman of the Board and Cindy Clark has been appointed President of the North Carolina Advanced Medical Technologies Center of Innovation (NC AMTC). The NC AMTC is a new non-profit corporation established to promote the growth of North Carolina’s advanced medical technologies industry. The NC AMTC has been awarded a four-year, $2.5 million grant from the North Carolina Biotechnology Center’s Centers of Innovation Program. The North Carolina Biosciences Organization (NCBIO) led a statewide effort to establish the NC AMTC, including the preparation of a preliminary business plan.

“This is the culmination of three years of intensive planning and market research,” said Sam Taylor, President of NCBIO. “We are delighted to have Greg’s 22 years of wisdom and guidance leading the board of directors and Cindy’s exceptional entrepreneurial talents full-time to promote the growth and development of the advanced medical technologies industry in North Carolina.”

Greg Davis is an experienced medical device executive with broad global and functional experience in finance, manufacturing, sales and general management. Greg is currently the CEO of Tryton Medical, Inc. Prior to joining Tryton Medical, Greg was president of Guidant Japan. Greg also managed Guidant’s product portfolio in 13 Asian countries and was instrumental in the start up and management of an FDA-regulated, Class III manufacturing facility in Dorado, Puerto Rico. Greg started his career in various financial management roles with Cardiac Pacemakers Incorporated and Eli Lilly in the U.S. and Puerto Rico. Greg holds a bachelors of science in mechanical engineering from the University of Minnesota and a masters of business administration from the University of Michigan.

Cindy Clark, J.D., has over 17 years of experience launching and leading early-stage life science companies. Most recently, she was the CEO of Sirga Advanced Biopharma, Inc. and NanIO Biosciences, Inc., and she remains on their boards of directors. She has held senior management positions at Phase Biosciences, Erimos Pharmaceuticals, MedCases, Bell Atlantic Internet Solutions, CV Therapeutics, and Univax Biologics (now NABI). She has a bachelors of arts degree in mathematics and government from Wesleyan University and a juris doctorate from the Washington College of Law, American University. “Cindy was selected after an extensive, nation-wide search for the new Center’s founding president. The hiring committee was impressed with her entrepreneurial experience and demonstrated ability to build alliances and deliver results,” states Greg Davis.

The advanced medical technologies industry, which includes devices, diagnostics, imaging agents and other medical technologies, is a burgeoning industry in North Carolina, with over 400 companies in this sector. “It is an honor to have been chosen to be one of the leading champions for this industry. I look forward to sharing many exciting announcements in the coming months as we launch this new organization. The AMT industry will be a driving force in the North Carolina life sciences community in the years to come,” states Cindy Clark, the new NC AMTC president.

The North Carolina Biotechnology Center is a private, non-profit corporation supported by the N.C. General Assembly. Its mission is to provide long-term economic and societal benefits to North Carolina by supporting biotechnology research, business, education and strategic policy statewide.

NCBIO is the trade association for North Carolina’s life science industry. Members include companies and research institutions working in the pharmaceutical, medical device, diagnostic, clinical research and agricultural biotechnology sectors, as well as firms and non-profits that provide support services to life science companies. Founded in 1993, NCBIO has been working for more than fifteen years to help the North Carolina’s life science community fulfill its extraordinary promise as a source of economic opportunity and improved quality of life.

Editors: Click for downloadable photographs of Greg Davis and Cindy Clark.

North Carolina Biosciences Organization (NCBIO)
Sam Taylor, 919-281-8960
staylor@ncbioscience.org


Copyright © 2008 Business Wire. All rights reserved.
Share/Save/Bookmark

Article : Chairman of the Board and President Announced to Lead the North Carolina Advanced Medical Technologies Center of Innovation
Print this article
Share this article

Stay Updated

News gadget on your Google homepage
Subscribe to a news feed in Google Reader



Related News

New Pacific Metals Corp. Announces Results for the Three Months Ended September 30, 2009
VANCOUVER, BRITISH COLUMBIA -- 11/26/09 -- New Pacific Metals Corp. (TSX VENTURE: NUX) (the "Company") announces its unaudited consolidated financial results for the three months ended September 30, 2009. All figures are expressed in Canadian dolla..

Diadem Announces Equity Financing to Raise Up to $750,000
MONTREAL, QUEBEC -- 11/26/09 -- Diadem Resources Ltd. (TSX VENTURE: DRL)("Diadem" or the "Company") announced today that it proposes to effect a non-brokered private placement of up to 15,000,000 Units at $0.05 per Unit to raise up to $750,000 of e..

World Food Funds Franchisor
Jorgan’s Foods, Inc. turned to World Food Association Organization to secure $12.6 million to refinance existing loans. The financing extinguishes 25 existing loan agreements before their scheduled maturity and is secured by existing real estate and business value. /I/P PScottsdal...

Dianor Announces Closing of Private Placement
VAL-D'OR, QUEBEC -- 11/26/09 -- Dianor Resources Inc. (TSX VENTURE: DOR) announces that it has completed a private placement by issuing an aggregate of 8,292,138 "flow-through" units to accredited investors in Saskatchewan and Nova Scotia and to th..

World Food Invests in Energy
World Food Association Organization is looking towards green alternative energy projects to pioneer the change in our planet's climate. The massive project is no small undertaking and World Food Association Organization has taken the helm position to ensure that it comes to fruition./I/P ...

First Gold Hires Investor Relations Firm
LAVAL, QUEBEC -- 11/26/09 -- First Gold Exploration Inc. (TSX VENTURE: EFG)(FRANKFURT: F12) is pleased to announce that it has engaged the services of National Media Associates, an independent firm of investor relations. National Media Associates w..

Media Release-KAIROS Partners Murdered in Philippines: A Response to the Massacre
TORONTO, ONTARIO -- 11/26/09 -- Attention: Religion, Foreign, and Human Rights Journalists KAIROS: Canadian Ecumenical Justice Initiatives condemns the murder of 57 people in the Philippines, including two of its human rights partners, an..

Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 
Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark
 
 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases

 


The Earth Times
News Category

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.